These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8201601)

  • 1. Molecular structures and conformational studies of triarylcyclopropyl and related nonsteroidal antiestrogens.
    Hossain MB; van der Helm D; Schmitz FJ; Pordesimo EO; Magarian RA; Meyer KL; Overacre LB; Day BW
    J Med Chem; 1994 May; 37(11):1670-83. PubMed ID: 8201601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of 1-(4-[2-(diethylamino)ethoxy]phenyl)-2-(4-methoxyphenyl)-1-phenylethan- 1-ol, the non-steroidal antiestrogen MER25.
    Hossain MB; Symersky J; Neely SC; van der Helm D; Magarian RA
    Acta Crystallogr C; 1993 Mar; 49 ( Pt 3)():500-4. PubMed ID: 8484922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of 1,1-dichloro-2-(4-methoxyphenyl)-2,3-diphenylcyclopropane.
    Du L; Hossain MB; Ji X; van der Helm D; Magarian RA; Day BW
    Acta Crystallogr C; 1992 May; 48 ( Pt 5)():887-91. PubMed ID: 1388936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of a series of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens.
    Day BW; Magarian RA; Jain PT; Pento JT; Mousissian GK; Meyer KL
    J Med Chem; 1991 Feb; 34(2):842-51. PubMed ID: 1995907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogens: future prospects.
    Howell A
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):59-64. PubMed ID: 9065930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural comparison of a gem-dichlorodiarylcyclopropane antiestrogen and three of its derivatives.
    Hossain MB; Wang JL; van der Helm D; Magarian RA; Griffin MT; Day BW
    Acta Crystallogr B; 1991 Aug; 47 ( Pt 4)():511-21. PubMed ID: 1930832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular structures, conformational analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs.
    Kym PR; Anstead GM; Pinney KG; Wilson SR; Katzenellenbogen JA
    J Med Chem; 1993 Nov; 36(24):3910-22. PubMed ID: 8254621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrogen receptor alpha-mediated transcription by antiestrogenic 1,1-dichloro-2,2,3-triarylcyclopropanes.
    Cheng P; Kanterewicz B; Hershberger PA; McCarty KS; Day BW; Nichols M
    Mol Pharmacol; 2004 Oct; 66(4):970-7. PubMed ID: 15235102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on the conformational flexibility of the antiestrogenic drug tamoxifen: preferred conformations in the free state and bound to the protein calmodulin.
    Edwards KJ; Laughton CA; Neidle S
    Acta Crystallogr B; 1992 Aug; 48 ( Pt 4)():511-4. PubMed ID: 1418821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens.
    Duax WL; Griffin JF; Weeks CM; Korach KS
    Environ Health Perspect; 1985 Sep; 61():111-21. PubMed ID: 3905370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
    Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
    Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational studies and electronic structures of tamoxifen and toremifene and their allylic carbocations proposed as reactive intermediates leading to DNA adduct formation.
    Kuramochi H
    J Med Chem; 1996 Jul; 39(15):2877-86. PubMed ID: 8709121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
    Magarian RA; Avor KS; Overacre LB; Kunchandy J; Paxton TR
    Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
    Jain PT; Pento JT; Magarian RA
    Anticancer Res; 1995; 15(6B):2529-32. PubMed ID: 8669818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of tissue selectivity in estrogen receptor modulators.
    Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of some N,N-diethyl-2-[(4'-substituted) phenylthio] acetamides.
    Vinhato E; Olivato PR; Zukerman-Schpector J; Dal Colle M
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():738-46. PubMed ID: 23886507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative X-ray and conformational analysis of a new crystal of 13α,21-dihydroeurycomanone with eurycomanone from Eurycoma longifolia and their anti-estrogenic activity using the uterotrophic assay.
    Teh CH; Abdulghani M; Morita H; Shiro M; Hussin AH; Chan KL
    Planta Med; 2011 Jan; 77(2):128-32. PubMed ID: 20665368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.